Berenice Y Gitomer
Overview
Explore the profile of Berenice Y Gitomer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Steele C, You Z, Gitomer B, Brosnahan G, Abebe K, Braun W, et al.
Kidney Int Rep
. 2022 Jan;
7(1):117-120.
PMID: 35005320
No abstract available.
12.
Pereira R, Gitomer B, Chonchol M, Harris P, Noche K, Salusky I, et al.
JBMR Plus
. 2021 Apr;
5(4):e10464.
PMID: 33869988
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of chronic kidney disease (CKD) and leads to a specific type of bone disease. The primary cilium is...
13.
Baliga M, Klawitter J, Christians U, Hopp K, Chonchol M, Gitomer B, et al.
Sci Rep
. 2021 Mar;
11(1):6629.
PMID: 33758231
Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease. Although children with ADPKD show normal renal function, cyst development is already occurring. In this study, we...
14.
Brosnahan G, You Z, Wang W, Gitomer B, Chonchol M
Curr Hypertens Rev
. 2020 Aug;
17(3):228-237.
PMID: 32807060
Background: Epidemiological studies have suggested that elevated serum uric acid may contribute to the progression of chronic kidney disease. However, no large prospective study has examined whether hyperuricemia is an...
15.
Hanudel M, Salusky I, Pereira R, Wang W, You Z, Nowak K, et al.
Kidney Int Rep
. 2019 Dec;
4(12):1742-1748.
PMID: 31844811
No abstract available.
16.
Kleczko E, Marsh K, Tyler L, Furgeson S, Bullock B, Altmann C, et al.
Kidney Int
. 2018 Sep;
94(6):1127-1140.
PMID: 30249452
Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent inherited nephropathy. To date, therapies alleviating the disease have largely focused on targeting abnormalities in renal epithelial cell signaling. ADPKD...
17.
Perrone R, Mouksassi M, Romero K, Czerwiec F, Chapman A, Gitomer B, et al.
Kidney Int Rep
. 2017 Nov;
2(3):451-460.
PMID: 29142972
Introduction: Total kidney volume (TKV) is a promising imaging biomarker for tracking and predicting the natural history of patients with autosomal dominant polycystic kidney disease. Methods: A drug development tool...
18.
Perrone R, Mouksassi M, Romero K, Czerwiec F, Chapman A, Gitomer B, et al.
Kidney Int Rep
. 2017 Nov;
2(3):442-450.
PMID: 29142971
Introduction: Autosomal dominant polycystic kidney disease is the most common hereditary kidney disease. TKV is a promising imaging biomarker for tracking and predicting the natural history of autosomal dominant polycystic...
19.
Perrone R, Neville J, Chapman A, Gitomer B, Miskulin D, Torres V, et al.
Am J Kidney Dis
. 2015 Jun;
66(4):583-90.
PMID: 26088508
Data standards provide a structure for consistent understanding and exchange of data and enable the integration of data across studies for integrated analysis. There is no data standard applicable to...
20.
Klawitter J, Zafar I, Klawitter J, Pennington A, Klepacki J, Gitomer B, et al.
BMC Nephrol
. 2013 Aug;
14:165.
PMID: 23902712
Background: We previously demonstrated that lovastatin decreases cyst volume and improves kidney function in the Han:SPRD (Cy/+) rat model of ADPKD. Since endothelial dysfunction and inflammatory activity are evident in...